KY SB192 | 2017 | Regular Session
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 14 2017 - 25% progression, died in committee
Action: 2017-02-15 - to Health & Welfare (S)
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on February 14 2017 - 25% progression, died in committee
Action: 2017-02-15 - to Health & Welfare (S)
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Draft #1) [PDF]
Summary
Amend KRS 218A.010 to modify a definition; amend KRS 218A.020 to require that controlled substances scheduled by the federal Controlled Substances Act be regulated in the same schedule as the federal schedule; establish a method to schedule in a more restrictive schedule at the state level; amend KRS 218A.202 to require certain hospitals to report positive toxicology screens to CHFS; permit federal prosecutors and agents to use KASPER; permit practitioners or pharmacists to review KASPER reports of birth mothers of potentially drug-exposed infants; remove a pilot program relating to real-time electronic monitoring; make other technical corrections; amend KRS 218A.240, 243.100, 243.390, 243.500, and 314.011 to conform; repeal KRS 218A.030, 218A.050, 218A.070, 218A.090, 218A.110, and 218A.130, relating to the previous controlled substances scheduling system.
Title
AN ACT relating to the monitoring of controlled substances.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2017-02-15 | Senate | to Health & Welfare (S) |
2017-02-14 | Senate | introduced in Senate |
Kentucky State Sources
Type | Source |
---|---|
Summary | http://www.lrc.ky.gov/record/17RS/SB192.htm |
Text | http://www.lrc.ky.gov/recorddocuments/bill/17RS/SB192/bill.pdf |